In this article, we take a look at two very up and coming stocks in Johnson & Johnson and Sarepta Therapeutics. Keep an eye out for Johnson & Johnson (NYSE JNJ) and Sarepta Therapeutics (NASDAQ SRPT). While at one hand, analysts are optimistic about Johnson & Johnson’s second quarter earnings, Sarepta Therapeutics would be looking…
Goldman Sachs has been hired by Shire as the London-listed drug maker confronts a takeover offer, as explained in the Financial Times morning briefing. Shire turned down a $46 billion bid from Chicago-based AbbVie last week. According to a report from the New-York Times, people briefed on the matter said AbbVie was likely to come…
A source familiar with the matter said on Saturday, Medical-device maker Medtronic Inc and rival Covidien, are in advanced talks to combine in a deal valued at $45 billion to $50 billion. The person said, asking not to be named because the matter is not public, the deal, which would allow Medtronic to be domiciled…
Peregrine Pharmaceuticals (NASDAQ:PPHM) is up nearly 20% and reached a 19-month high after the biopharmaceutical company said Wednesday that it will present data from three preclinical studies highlighting the immuno-oncology and anti-viral potential of phosphatidylserine (PS)-targeting antibodies. Results will be presented at two upcoming Keystone Symposia to be held March 9-13. Shares of Peregrine (NASDAQ:PPHM) are…
Nymi, The Heartwave-Sensing wristband, relies on authenticating identity by matching the overall shape of the user’s heartwaveRead More >>
